Plasma antioxidants and cognitive performance in middle-aged and older adults: Results of the Austrian stroke prevention study

Journal of the American Geriatrics Society

Volumn 46, Issue 11, 1998, Pages 1407-1410

  Schmidt, R ^a   Hayn, M ^a   Reinhart, B ^a   Roob, G ^a   Schmidt, H ^a   Schumacher, M ^a   Watzinger, N ^a   Launer, L J ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CANTHAXANTHIN; CRYPTOXANTHIN; GAMMA TOCOPHEROL; LYCOPENE; RETINOL; XANTHOPHYLL;

ADULT; AGED; ARTICLE; AUSTRIA; COGNITION; DIET SUPPLEMENTATION; DRUG BLOOD LEVEL; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; REGRESSION ANALYSIS; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; STROKE; TREATMENT OUTCOME; VITAMIN INTAKE;

EID: 0031730398     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1998.tb06008.x     Document Type: Article

References (20)

1. Sano M, Ernesto C, Thomas RG et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-1222.
2. Schmidt R, Hayn M, Fazekas F et al. Magnetic resonance imaging white matter hyperintensities in clinically normal elderly individuals: Correlations with plasma concentrations of naturally occurring antioxidants. Stroke 1996;27:2043-2047.
3. Pantoni L, Garcia JH. The significance of cerebral white matter abnormalities 100 years after Binswanger's report: A review. Stroke 1995;26:1293-1301.
4. Jama JW, Launer LJ, Witteman JCM et al. Dietary antioxidants and cognitive function in a population-based sample of older persons: The Rotterdam Study. Am J Epidemiol 1996;144:275-280.
5. Masaki K, White L, Petrovic H et al. Superior cognitive functioning in later life. Neurol (abstract) 1995;45(suppl 4):A271-272.
6. Kalmijn S, Feskens EJM, Launer LJ, Kromhout D. Polyunsaturated fatty acids, antioxidants and cognitive function in very old men. Am J Epidemiol 1997;145:33-41.
7. Goodwin JS, Goodwin JM, Garry PJ. Association between nutritional status and cognitive functioning in a healthy elderly population. JAMA 1983;249: 2917-2921.
8. Perrig WJ, Perrig P, Stähelin HB. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 1997;45: 718-724.
9. Schmidt R, Lechner H, Fazekas F et al. Assessment of cerebrovascular risk profiles in healthy persons: Definition of research goals and the Austrian Stroke Prevention Study (ASPS). Neuroepidemiology 1994;13:308-313.
10. WHO. World Health Statistics Annual: The WHO MONICA Project. Geneva: World Health Organization, 1989, pp 27-149.
11. Mattis S. Mental status examination for organic mental syndrome in the elderly patient. In: Bellak L, Karasu TE, eds. Geriatric Psychiatry. New York: Grune & Stratton, 1976, pp 77-121.
12. Hodges JR. Cognitive Assessment for Clinicians. Oxford: Oxford Medical Publications, 1996.
13. Schmidt R, Freidl W, Fazekas F et al. The Mattis Dementia Rating Scale: Normative data from 1,001 healthy volunteers. Neurology 1994;44:964-966.
14. Bleecker ML, Bolla-Wilson K, Kawas C, Agnew J. Age-specific norms for the Mini-Mental State Exam. Neurology 1988;38:1565-1568.
15. Gey KF, Staehlin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Invest 1993;71:3-6.
16. Desmond DW, Tatemichi TK, Paik M, Stern Y. Risk factors for cerebrovascular disease as correlates of cognitive function in a stroke-free cohort. Arch Neurol 1993;50:162-166.
17. Sowell AL, Huff DL, Yeager PR et al. Retinol, alpha-tocopherol, lutein/zeaxanthin, beta-cryptoxanthin, lycopene, alpha-carotene, trans-beta-carotene, and four retinyl esters in serum determined simultaneously by reversed-phase HPLC with multi-wavelength detection. Clin Chem 1994;40:411-416.
18. Cantilena LR, Stukel TA, Greenberg ER et al. Diurnal and seasonal variation of five carotenoids measured in human serum. Am J Clin Nutr 1992;55: 659-663.
19. Dyrks T, Dyrks E, Hartmann T et al. Amyloidogenicity of βA4 and βA4-bearing APP fragments by metal catalysed oxidation. J Biol Chem 1992;267: 18210-18217.
20. Rosenblum WI, Nelson GH, Bel RA et al. Vitamin E ameliorates adverse effects of endothelial injury in brain arterioles. Am J Physiol 1996;271: H637-642.